Clinical Research
Along with normal clinical service, wide range of clinical trials also provided in our center
We are actively recruiting patient to participate in the following clinical trials
Please send referral letter to medicaloncology@hku.hk if interested
Recruiting clinical Trials
Breast Cancer
Protocol Number
Protocol Title
Experimental agent
Principle Investigator
OBI-822-011
The GLORIA Study: A Phase 3, Randomized, Open-Label Study of the Anti-Globo H Vaccine Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients with High-Risk, Early-Stage Globo H-Positive Triple Negative Breast Cancer
OBI-822, OBI-821
VS
Placebo
GS-US-592-6173 (Ascent -04)
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer, Whose Tumors Express PD-L1
Sacituzumab Govitecan-hziy (SG) + Pembrolizumab
VS
Pembrolizumab + Treatment of Physician's Choice (TPC)
GS-US-586-6144
A Phase 2 Study of Magrolimab Combination Therapy in Patients With Unresectable, Locally Advanced or Metastatic Triple-Negative Breast Cancer
Magrolimab + Nab-Paclitaxel or Paclitaxe
VS
Nab-Paclitaxel or Paclitaxe